For the second time, GOP leaders postponed a scheduled bill vote after running into objections from conservatives and moderates. » Read More
By: Evelyn Cheng
Health-care stock performance diverged Friday after the controversial GOP health care bill was pulled from the floor of the House. » Read More
By: Jacob Pramuk
Republicans will turn their focus to tax reform after getting dealt a blow in their first major policy effort. » Read More
"We came really close today, but we came up short," Ryan said. » Read More
Patients missing out on their medication or taking the wrong dose costs the U.S. health care system $290 billion each year, according to a new report.
CVS Health's new "excluded" list includes medications used in treatment of patients with cancer, diabetes and hepatitis C.
Biogen shares soared on reports the company has drawn takeover interest from rival companies, the Wall Street Journal said.
CDC Director Tom Frieden says pregnant women all over the South should protect themselves against mosquito bites because of the risk of Zika.
Pfizer's results were driven by lower taxes and demand for new medicines, but it stuck to its previous sales and profit forecasts for the full year.
Theranos CEO Elizabeth Holmes pledged on Monday to increase transparency regarding its testing methods.
Most claims of opioid dependence involved adults between the ages of 19 and 35.
Theranos CEO Elizabeth Holmes will make her case to the biggest summit of experts in her field, but can she convince them her technology works?
Biogen and Ionis Pharmaceuticals shares soared after an analysis showed a drug for a deadly muscle disorder in infants met its main goal.
GlaxoSmithKline and Alphabet's life sciences unit are creating a new company focused on fighting diseases.
Seres Therapeutics shares plummeted more than 76 percent after its drug for preventing a bacterial infection of the large intestine failed.
Florida Gov. Rick Scott said that his state has become the first state in the nation to have the Zika virus transmitted locally via mosquitoes.
AbbVie's quarterly net revenue jumped 17.8 percent, driven by demand for its top-selling treatment, Humira.
The company's new tool will give small companies a quick, easy way to evaluate group plan costs.
New overall quality star ratings can help consumers chose among hospitals for themselves and loved ones.
Alere is still is trying to close its multibillion-dollar purchase by Abbott Labs.
"Consumers got better coverage" even as the average premiums paid for individual health plans dropped in 2014, an analysis found.
A proposal is the latest Obama administration effort to shift medical providers away from a fee-for-service model.
Only an estimated 3 to 37 people out of thousands of travelers to the Olympics are projected to return infected with Zika, according to a new study.
Olympus Corp. issued no broad warnings about scope infection risk in America in 2013 or two years afterward despite doing so in Europe.
Get the best of CNBC in your inbox